Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.

BACKGROUND: The candidate malaria vaccine RTS,S/AS01E has entered phase 3 trials, but data on long-term outcomes are limited. METHODS: For 4 years, we followed children who had been randomly assigned, at 5 to 17 months of age, to receive three doses of RTS,S/AS01E vaccine (223 children) or rabies va...

Descrición completa

Detalles Bibliográficos
Main Authors: Olotu, A, Fegan, G, Wambua, J, Nyangweso, G, Awuondo, K, Leach, A, Lievens, M, Leboulleux, D, Njuguna, P, Peshu, N, Marsh, K, Bejon, P
Formato: Journal article
Idioma:English
Publicado: 2013

Títulos similares

Títulos similares